Venom far exceeded expectations at the box office and now analysts have weighed in on the likelihood of Marvel Studios ever regaining the rights to the wall-crawler. Alas, it's not looking good...

Thanks to the Fox/Disney merger, the X-Men and Fantastic Four are returning home to the Marvel Cinematic Universe but fans hoping that Spider-Man and his supporting cast could become a permanent part of the Marvel Studios roster may be setting themselves up for disappointment.



After Venom grossed over $500 million (so far) at the worldwide box office, Sony Pictures is riding high on the success of its first Spider-Man-less Spider-Man spinoff. As a result, box office analysts are adamant that there's no way the studio will be parting with the IP any time soon, something which makes sense considering how many live-action Spider-Verse spinoffs are in the works.

"If it had failed, there is a chance Sony would have definitely returned to the bargaining table with Disney. Now, that's up in the air," explains Exhibitor Relations' senior box-office analyst Jeff Bock.